Clinical Trials Browser

Oligodendroglioma × Nivolumab × Clear all

NCT07031765 2025-12-18

Peds CHAMP1ON

Phase 1 Active not recruiting

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma

NCT03014804 2020-07-24

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma

Phase 2 Withdrawn

Glioblastoma, Oligodendroglioma, Gliosarcoma